# A Study of the Natural History of Participants With LGMD2E/R4, LGMD2D/R3, LGMD2C/R5, and LGMD2A/R1 ≥ 4 Years of Age, Who Are Managed in Routine Clinical Practice

> **NCT04475926** · — · ACTIVE_NOT_RECRUITING · sponsor: **Sarepta Therapeutics, Inc.** · enrollment: 205 (actual)

## Conditions studied

- Limb-girdle Muscular Dystrophy

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT04475926
- **Lead sponsor:** Sarepta Therapeutics, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2021-04-22
- **Primary completion:** 2030-09-05
- **Final completion:** 2030-09-05
- **Target enrollment:** 205 (ACTUAL)
- **Last updated:** 2025-11-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04475926

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04475926, "A Study of the Natural History of Participants With LGMD2E/R4, LGMD2D/R3, LGMD2C/R5, and LGMD2A/R1 ≥ 4 Years of Age, Who Are Managed in Routine Clinical Practice". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT04475926. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*